GENTILIN, Erica
 Distribuzione geografica
Continente #
NA - Nord America 3.309
EU - Europa 872
AS - Asia 448
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
OC - Oceania 1
Totale 4.638
Nazione #
US - Stati Uniti d'America 3.306
CN - Cina 314
UA - Ucraina 209
DE - Germania 153
IT - Italia 136
PL - Polonia 136
TR - Turchia 126
GB - Regno Unito 99
SE - Svezia 63
FI - Finlandia 54
BE - Belgio 12
RU - Federazione Russa 5
VN - Vietnam 5
CA - Canada 3
EU - Europa 3
BR - Brasile 2
FR - Francia 2
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
ID - Indonesia 1
IR - Iran 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 4.638
Città #
Woodbridge 417
Fairfield 380
Chandler 323
Ashburn 303
Houston 298
Jacksonville 258
Ann Arbor 206
Seattle 155
Wilmington 142
Warsaw 136
Cambridge 120
Addison 83
Izmir 68
Beijing 62
Nanjing 60
Ferrara 56
Princeton 55
Boardman 46
Milan 34
San Diego 29
Dearborn 24
Nanchang 24
Shanghai 24
Bremen 21
Shenyang 19
Washington 19
Changsha 17
Hebei 17
Mountain View 15
Jinan 14
Tianjin 14
Jiaxing 13
Brussels 11
Padova 11
Auburn Hills 9
Orange 9
Falls Church 8
New York 8
Tappahannock 8
Guangzhou 7
Indiana 7
Kunming 7
Norwalk 7
Redwood City 6
Dong Ket 5
Los Angeles 5
Bologna 4
Cagliari 4
Helsinki 4
Lanzhou 4
Leawood 4
London 4
Chengdu 3
Des Moines 3
Hefei 3
Ningbo 3
Rome 3
Taizhou 3
Walnut 3
Zhengzhou 3
Augusta 2
Kingston 2
Munich 2
San Francisco 2
Taiyuan 2
Ardabil 1
Arezzo 1
Bekasi 1
Canaro 1
Changchun 1
Chisinau 1
Chongqing 1
Dongguan 1
Formia 1
Fuzhou 1
Genova 1
Hangzhou 1
Harbin 1
Islamabad 1
Kilburn 1
Knoxville 1
Lappeenranta 1
Las Cruces 1
Linares 1
Monmouth Junction 1
Muizenberg 1
Navegantes 1
Nürnberg 1
Redmond 1
Simi Valley 1
Southwark 1
Stra 1
Toronto 1
Tosagua 1
Wuhan 1
Xian 1
Yellow Springs 1
Totale 3.650
Nome #
Studio dell’azione del Mitotane, farmaco adrenolitico, sulla funzionalità ipofisaria 197
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 156
Igf-I influences everolimus activity in medullary thyroid carcinoma 155
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 128
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 128
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 127
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 123
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 121
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 120
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 118
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 114
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 113
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 112
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 112
Functional characterization of a new deletion in CDKN1B 5'-UTR region 112
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 111
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 107
Proto-oncogene PBF/PTTG1IP Regulates Thyroid Cell Growth and Represses Radioiodide Treatment 106
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. 104
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 102
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 102
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 102
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 99
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 95
null 92
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 91
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 89
Growth hormone induces chemoresistance in breast cancer cells 87
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 83
null 81
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 79
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 76
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 72
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 71
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 70
ctivation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion 66
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 65
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 65
Targeting PKC in human pancreatic neuroendocrine tumor cells 64
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 64
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 62
miR-26a targets PRKCD in ACTH pituitary adenoma 60
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 53
MicroRNAs in the pituitary 52
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 51
Validation of a murine model to study deregulated pituitary microRNA 51
Therapeutic concentrations of mitotane inhibit thyrotroph cell viability and TSH secretion in a mouse cell line model 51
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 50
PI3K/Akt/mTOR pathway involvement in regulating growth hormone secretion in a rat pituitary adenoma cell line 44
null 40
miR-26a and cell cycle control in ACTH secreting pituitary adenoma 30
CDK-Inhibitors as New Therapeutic Treatment for Human Bronchial Carcinoids 24
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  16
Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors 16
Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines 15
Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line 3
Totale 4.697
Categoria #
all - tutte 15.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019351 0 0 0 0 0 0 0 0 0 0 139 212
2019/20201.080 166 39 36 163 75 135 94 101 83 121 42 25
2020/2021683 58 52 31 99 32 74 19 84 14 82 94 44
2021/2022504 26 37 31 7 22 31 22 17 15 50 53 193
2022/2023678 61 52 28 99 112 90 36 53 92 4 23 28
2023/2024290 32 36 25 11 39 56 15 69 4 3 0 0
Totale 4.697